A diagnostic rule for acute gouty arthritis in primary care without joint fluid analysis

Archives of Internal Medicine

Volumn 170, Issue 13, 2010, Pages 1120-1126

  Janssens, Hein J E M ^a   Fransen, Jaap ^a   Van De Lisdonk, Eloy H ^a   Van Riel, Piet L C M ^a   Van Weel, Chris ^a   Janssen, Matthijs ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RIJNSTATE HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

URATE; URIC ACID;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CRYSTAL; DIABETES MELLITUS; FEMALE; GENERAL PRACTITIONER; GOUT; HUMAN; HYPERTENSION; INTERNAL VALIDITY; JOINT ASPIRATION; MAJOR CLINICAL STUDY; MALE; METATARSOPHALANGEAL JOINT; MONARTHRITIS; PERFORMANCE; POPULATION; PREDICTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; SKIN REDNESS; URIC ACID BLOOD LEVEL;

ACUTE DISEASE; ARTHRITIS, GOUTY; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; ROC CURVE; SYNOVIAL FLUID; URIC ACID;

EID: 77954568211     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2010.196     Document Type: Article

References (25)

1. Arromdee E, Michet CJ, Crowson CS, O'Fallon WM, Gabriel SE. Epidemiology of gout: is the incidence rising? J Rheumatol. 2002;29(11):2403-2406. (Pubitemid 35266034)
2. Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Schumacher HR Jr, Saag KG. Gout epidemiology: results from the UK General Practice Research Database, 1990-1999. Ann Rheum Dis. 2005;64(2):267-272.
3. Lawrence RC, Helmick CG, Arnett FC, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998;41(5):778-799.
4. Zhang W, Doherty M, Pascual E, et al; EULAR Standing Committee for International Clinical Studies Including Therapeutics. EULAR evidence based recommendations for gout, part I: diagnosis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2006;65(10):1301-1311.
5. Rott KT, Agudelo CA. Gout. JAMA. 2003;289(21):2857-2860.
6. Pal B, Foxall M, Dysart T, Carey F, Whittaker M. How is gout managed in primary care? a review of current practice and proposed guidelines. Clin Rheumatol. 2000; 19(1):21-25.
7. Gorter KJ, Tan G, Verstappen WHJM, et al. NHG-standaard Jicht [NHG practice guideline "gout"]. Huisarts Wet. 2001;44:304-313.
8. Rainer TH, Graham CA. A significant step forward for gout. Lancet. 2008;371(9627): 1816-1818.
9. Janssens HJ, Janssen M, van de Lisdonk EH, van Riel PL, van Weel C. Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial. Lancet. 2008;371(9627):1854-1860.
10. Nagelkerke NJ. A note on a general definition of the coefficient of determination. Biometrika. 1991;78:691-692.
11. Vergouwe Y, Steyerberg EW, Eijkemans MJ, Habbema DF. Validity of prognostic models: when is a model clinically useful? Semin Urol Oncol. 2002;20(2):96-107. (Pubitemid 34522547)
12. Steyerberg EW, Eijkemans MJ, Harrell FE Jr, Habbema JD. Prognostic modeling with logistic regression analysis: a comparison of selection and estimation methods in small data sets. Stat Med. 2000;19(8):1059-1079.
13. Bleeker SE, Moll HA, Steyerberg EW, et al. External validation is necessary in prediction research: a clinical example. J Clin Epidemiol. 2003;56(9):826-832.
14. Zhang W, Doherty M, Bardin T, et al; EULAR Standing Committee for International Clinical Studies Including Therapeutics. EULAR evidence based recommendations for gout, part II: management: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2006;65(10):1312-1324.
15. Janssens HJ, van de Lisdonk EH, Bor H, van den Hoogen HJ, Janssen M. Gout, just a nasty event or a cardiovascular signal? a study from primary care. Fam Pract. 2003;20(4):413-416.
16. Krishnan E, Baker JF, Furst DE, Schumacher HR. Gout and the risk of acute myocardial infarction. Arthritis Rheum. 2006;54(8):2688-2696.
17. Fox R. Management of recurrent gout. BMJ. 2008;336(7639):329.
18. Petersel D, Schlesinger N. Treatment of acute gout in hospitalized patients. J Rheumatol. 2007;34(7):1566-1568. (Pubitemid 47067996)
19. Lawry GV II, Fan PT, Bluestone R. Polyarticular versus monoarticular gout: a prospective, comparative analysis of clinical features. Medicine (Baltimore). 1988; 67(5):335-343.
20. Lumbreras B, Pascual E, Frasquet J, González-Salinas J, Rodríguez E, Hernández-Aguado I. Analysis for crystals in synovial fluid: training of the analysts results in high consistency. Ann Rheum Dis. 2005;64(4):612-615.
21. Savolainen E, Kaipiainen-Seppänen O, Kröger L, Luosujärvi R. Total incidence and distribution of inflammatory joint diseases in a defined population: results from the Kuopio 2000 Arthritis Survey. J Rheumatol. 2003;30(11):2460-2468.
22. van der Helm-van Mil AH, le Cessie S, van Dongen H, Breedveld FC, Toes RE, Huizinga TW. A prediction rule for disease outcome in patients with recentonset undifferentiated arthritis: how to guide individual treatment decisions. Arthritis Rheum. 2007;56(2):433-440.
23. Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yü TF. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum. 1977;20(3):895-900.
24. Malik A, Schumacher HR, Dinnella JE, Clayburne GM. Clinical diagnositic criteria for gout: comparison with the gold standard of synovial fluid crystal analysis. J Clin Rheumatol. 2009;15(1):22-24.
25. Janssens HJ, Janssen M, van de Lisdoonk EH, Fransen J, van Riel PL, van Weel C Limited validity of the American College of Rheumatology criteria for classifying patients with gout in primary care [published ahead of print March 16, 2010]. Ann Rheum Dis. http://ard.bmj.com/content/early/2010/03/12/ard.2009. 123687 .extract. Accessed April 22, 2010.